RANKL inhibition with denosumab increases bone mineral density in patients with rheumatoid arthritis

被引：0
|
作者：
Dore, R. K.
Hurd, E.
Palmer, W.
Shergy, W.
Zhou, L.
Newmark, R.
Tsuji, W.
机构：
[1] Robin K Dore MD Inc, Anaheim, CA USA
[2] Ctr Arthritis, Dallas, TX USA
[3] Westroads Med Grp, Omaha, NE USA
[4] Rheumatol Assoc N Alabama, Huntsville, AL USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] Denosumab increases bone mineral density in patients with rheumatoid arthritis.
    Dore, R.
    Hurd, E.
    Palmer, W.
    Shergy, W.
    Zhou, L.
    Newmark, R.
    Tsuji, W.
    Dore, Robin K.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S240 - S240
  • [2] Denosumab increases bone mineral density in patients with rheumatoid arthritis: 12-month results
    Dore, R. K.
    Hurd, E.
    Palmer, W.
    Shergy, W.
    Lane, N.
    Cohen, S.
    Zhou, L.
    Newmark, R.
    Tsuhji, W.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S59 - S59
  • [3] Inhibition of RANKL with denosumab reduces markers of bone and cartilage turnover in patients with rheumatoid arthritis
    Lane, N.
    Iannini, M.
    Atkins, C.
    Haraoui, B.
    Zhou, L.
    Tsuji, W.
    Newmark, R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S17 - S18
  • [4] Infliximab increases bone mineral density in patients with rheumatoid arthritis
    Katherine Sole
    Nature Clinical Practice Rheumatology, 2006, 2 (3): : 120 - 120
  • [5] RANKL inhibition with denosumab decreases markers of bone and cartilage turnover in patients with rheumatoid arthritis.
    Lane, N. E.
    Iannini, M.
    Atkins, C.
    Haraoui, B.
    Zhou, L.
    Tsuji, W.
    Newmark, R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S225 - S226
  • [6] Inhibiting RANKL with denosumab increases bone mineral density in patients with rheumatoid arthritis: 6-month results from a randomized, placebo-controlled trial
    Dore, R. K.
    Hurd, E.
    Palmer, W. R.
    Shergy, W.
    Zhous, L.
    Newmarks, R.
    Tsuji, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 428 - 429
  • [7] THE INFLUENCE OF DENOSUMAB ON BONE MINERAL DENSITY, STRUCTURAL DAMAGE IN PATIENTS WITH OSTEOPOROSIS AND RHEUMATOID ARTHRITIS
    Dydykina, P.
    Petrova, E.
    Dydykina, I.
    Smirnov, A.
    Glukhova, S.
    Alexeeva, L.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1021 - 1021
  • [8] Effects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritis
    Takeshi Mochizuki
    Koichiro Yano
    Katsunori Ikari
    Kosei Kawakami
    Ryo Hiroshima
    Naoko Koenuma
    Mina Ishibashi
    Shigeki Momohara
    Journal of Bone and Mineral Metabolism, 2018, 36 : 431 - 438
  • [9] Effects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritis
    Mochizuki, Takeshi
    Yano, Koichiro
    Ikari, Katsunori
    Kawakami, Kosei
    Hiroshima, Ryo
    Koenuma, Naoko
    Ishibashi, Mina
    Momohara, Shigeki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2018, 36 (04) : 431 - 438
  • [10] Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis
    Nakamura, Yukio
    Suzuki, Takako
    Kato, Hiroyuki
    ARCHIVES OF OSTEOPOROSIS, 2017, 12 (01)
12345